Webinar

Implementing CORE20plus5: demonstrating impact for cancer and CVD patients

Join us for this panel discussion on key issues and actions to support the reduction of health inequalities at both national and system level.
Book to attend External link icon

General information

Time
25 October 2022 08:00 - 09:00 GMT
Audience
Open to all

Speakers

  • Image Liz Bishop
    Liz Bishop External link icon
    CEO, The Clatterbridge Cancer Centre NHS Foundation Trust & SRO of Cheshire & Merseyside Cancer Alliance
  • Matt Kearney
    Dr Matt Kearney External link icon
    Executive Clinical Director for Cardiovascular Health UCLPartners Academic Health Science Network
  • Ming Tang
    Ming Tang External link icon
    Chief Data and Analytics Officer, NHS England
  • Fiona Bride
    Fiona Bride External link icon
    Head of Value and Access, Innovative medicines, Novartis UK
  • Joan Saddler
    Joan Saddler OBE
    Director of Partnerships and Equality, NHS Confederation NHS Confederation

How can healthcare systems, their leaders and partnerships make demonstrable impact on tackling health inequalities for Cancer and cardiovascular disease (CVD) patients? How can data support a targeted approach, differential resourcing, and measure the impact of interventions? Colleagues throughout healthcare systems are working in innovative ways to address these questions. Join us for this interactive panel discussion on key issues and actions to support the reduction of health inequalities at both national and system level.

Learning objectives:

  • Understand the local and national challenges in tackling health inequalities
  • Explore examples of how Core20PLUS5 has enabled a targeted approach for specific patient populations
  • Discuss good practice of where data can be utilised to target populations/geographies, support differential resourcing and measure the impact of interventions

This activity is being delivered as part of the NHS Confederation and Novartis Pharmaceuticals UK Collaborative Working Agreement.